A useful testing strategy in phase iii trials: combined test of superiority and test of equivalence
Author:
Affiliation:
1. a Pharmaceutical Development Division , Takeda Chemical Industries, Ltd. , 4-l-1, Doshomachi, Chuo-ku, Osaka, 541, Japan
Publisher
Informa UK Limited
Subject
Pharmacology (medical),Pharmacology,Statistics and Probability
Link
https://www.tandfonline.com/doi/pdf/10.1080/10543409508835115
Reference8 articles.
1. On closed testing procedures with special reference to ordered analysis of variance
2. One-sided or two-sided ρ values: which most appropriately address the question of drug efficacy?
3. Some thoughts on the one-sided and two-sided tests
4. The use of one-sided tests in drug trials: an fda advisory committee member's perspective
5. A comment concerning one-sided tests of significance in new drug applications
Cited by 135 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. A Joint Equivalence and Difference (JED) Test for Practical Use in Controlled Trials;Journal of Data Science;2024
2. A comparison of Er,Cr:YSGG laser to minimally invasive surgical technique in the treatment of intrabony defects: Twelve‐month results of a multicenter, randomized, controlled study;Journal of Periodontology;2023-10-17
3. A Home-Mailed Versus General Practitioner-Delivered Vaginal Self-Sampling Kit for Cervical Cancer Screening: A Cluster Randomized Controlled Trial with a Cost-Effectiveness Analysis;Journal of Women's Health;2022-07-13
4. Outcomes Following Severe Distal Tibial, Ankle, and/or Mid/Hindfoot Trauma;Journal of Bone and Joint Surgery;2021-05-12
5. Safety and Efficacy of a Preservative-Free Artificial Tear Containing Carboxymethylcellulose and Hyaluronic Acid for Dry Eye Disease: A Randomized, Controlled, Multicenter 3-Month Study;Clinical Ophthalmology;2020-10
Safety and Efficacy of a Preservative-Free Artificial Tear Containing Carboxymethylcellulose and Hyaluronic Acid for Dry Eye Disease: A Randomized, Controlled, Multicenter 3-Month Study
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3